Word

Status

Registered

Status Code

700

Status Date

Tuesday, May 21, 2019

Serial Number

87802745

Registration Number

5754567

Registration Date

Tuesday, May 21, 2019

Mark Type

2000

Filing Date

Monday, February 19, 2018

Published for Opposition

Tuesday, March 5, 2019

Trademark Owner History

IOmx Therapeutics AG - Original Registrant

Classifications

5 Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases, disorders and conditions, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions

10 Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit; Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit; Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit

42 Scientific services, namely, scientific research, analysis and testing in the fields of biology, chemistry or medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry; Scientific services, namely, scientific research, analysis and testing in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents, and diagnostic apparatus; Design and development of computer software for database management, cloud-storage of data, data-management, data-query, data-analysis and data-presentation, for the query, analysis and presentation of the sequence or structure of molecules, or for predicting or providing a medical diagnosis or prognosis, as well as for controlling and managing patient medical information, with any of the aforementioned services for use in the fields of biology, chemistry or medicine, as well as for use in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry; Design and development of computer software for database management, cloud-storage of data, data-management, data-query, data-analysis and data-presentation, as well as for the query, analysis and presentation of the sequence or structure of molecules, or for predicting or providing a medical diagnosis or prognosis, with any of the aforementioned services for use in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents, and diagnostic apparatus

The mark consists of a square image with rounded corners, where the upper and left side is depicted in light blue, and the lower and right side in gray, separated by a curving empty line that coincides at the center around a light blue dot, and the negative space creates the appearance of a collision with three triangular points on either side. The light blue and grey areas of the square each contain two white dots trailing a single triangular line, also in white.
The color(s) Dark Grey, Light Blue and White is/are claimed as a feature of the mark.

Trademark Events

Feb 8, 2024

Teas Change Of Correspondence Received

Feb 8, 2024

Teas Change Of Domestic Representatives Address

Feb 8, 2024

Teas Withdrawal As Domestic Representative Received

Feb 8, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Feb 8, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Feb 8, 2024

Applicant/Correspondence Changes (Non-Responsive) Entered

Feb 8, 2024

Teas Change Of Owner Address Received

Mar 6, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Mar 6, 2023

Teas Change Of Correspondence Received

Mar 6, 2023

Teas Change Of Domestic Representatives Address

Mar 6, 2023

Teas Withdrawal Of Attorney Received-Firm Retains

Mar 6, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Mar 6, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Mar 6, 2023

Teas Change Of Owner Address Received

Oct 8, 2021

Teas Change Of Correspondence Received

Oct 8, 2021

Teas Withdrawal As Domestic Representative Received

Oct 8, 2021

Teas Withdrawal Of Attorney Received-Firm Retains

Oct 8, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 8, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

May 21, 2019

Registered-Principal Register

Mar 5, 2019

Official Gazette Publication Confirmation E-Mailed

Mar 5, 2019

Published For Opposition

Feb 13, 2019

Notification Of Notice Of Publication E-Mailed

Jan 25, 2019

Approved For Pub - Principal Register

Jan 19, 2019

Teas/Email Correspondence Entered

Jan 18, 2019

Correspondence Received In Law Office

Jan 18, 2019

Teas Request For Reconsideration Received

Dec 20, 2018

Notification Of Final Refusal Emailed

Dec 20, 2018

Final Refusal E-Mailed

Dec 20, 2018

Final Refusal Written

Dec 12, 2018

Teas/Email Correspondence Entered

Dec 12, 2018

Correspondence Received In Law Office

Dec 4, 2018

Teas Response To Office Action Received

Jun 6, 2018

Notification Of Non-Final Action E-Mailed

Jun 6, 2018

Non-Final Action E-Mailed

Jun 6, 2018

Non-Final Action Written

Jun 4, 2018

Assigned To Examiner

Apr 3, 2018

Preliminary/Voluntary Amendment - Entered

Mar 30, 2018

Assigned To Lie

Mar 16, 2018

Teas Voluntary Amendment Received

Feb 27, 2018

Notice Of Design Search Code E-Mailed

Feb 26, 2018

New Application Office Supplied Data Entered

Feb 22, 2018

New Application Entered